ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 100 filers reported holding ANTARES PHARMA INC in Q2 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,364,000 | +17.2% | 1,353,970 | -16.6% | 0.41% | +2.7% |
| Q3 2019 | $5,432,000 | +1.5% | 1,623,970 | -0.2% | 0.40% | -4.0% |
| Q2 2019 | $5,351,000 | +8.6% | 1,626,500 | 0.0% | 0.42% | +2.9% |
| Q1 2019 | $4,928,000 | -4.5% | 1,626,500 | -14.2% | 0.41% | -15.0% |
| Q4 2018 | $5,158,000 | -28.9% | 1,896,500 | -12.1% | 0.48% | -31.7% |
| Q3 2018 | $7,253,000 | +15.5% | 2,158,500 | -11.3% | 0.70% | +8.3% |
| Q2 2018 | $6,278,000 | – | 2,433,500 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |